Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita
- PMID: 20453831
- PMCID: PMC2885924
- DOI: 10.1038/emboj.2010.83
Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita
Abstract
Defects in ribosome biogenesis and function are present in a growing list of human syndromes associated with cancer susceptibility. One example is X-linked dyskeratosis congenita (X-DC) in which the DKC1 gene, encoding for an enzyme that modifies ribosomal RNA, is found to be mutated. How ribosome dysfunction leads to cancer remains poorly understood. A critical cellular response that counteracts cellular transformation is oncogene-induced senescence (OIS). Here, we show that during OIS, a switch between cap- and internal ribosome entry site (IRES)-dependent translation occurs. During this switch, an IRES element positioned in the 5'untranslated region of p53 is engaged and facilitates p53 translation. We further show that in DKC1(m) cells, p53 IRES-dependent translation is impaired during OIS ex vivo and on DNA damage in vivo. This defect in p53 translation perturbs the cellular response that counteracts oncogenic insult. We extend these findings to X-DC human patient cells in which similar impairments in p53 IRES-dependent translation are observed. Importantly, re-introduction of wild-type DKC1 restores p53 expression in these cells. These results provide insight into the basis for cancer susceptibility in human syndromes associated with ribosome dysfunction.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures







Similar articles
-
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.Science. 2006 May 12;312(5775):902-6. doi: 10.1126/science.1123835. Science. 2006. PMID: 16690864
-
Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.Hum Mutat. 2013 Dec;34(12):1698-707. doi: 10.1002/humu.22447. Epub 2013 Oct 21. Hum Mutat. 2013. PMID: 24115260
-
p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.Clin Transl Oncol. 2014 Jun;16(6):529-38. doi: 10.1007/s12094-013-1112-3. Epub 2013 Sep 25. Clin Transl Oncol. 2014. PMID: 24065372
-
Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway.Wiley Interdiscip Rev RNA. 2011 Jul-Aug;2(4):507-22. doi: 10.1002/wrna.73. Epub 2011 Jan 20. Wiley Interdiscip Rev RNA. 2011. PMID: 21957040 Review.
-
Turning Uridines around: Role of rRNA Pseudouridylation in Ribosome Biogenesis and Ribosomal Function.Biomolecules. 2018 Jun 5;8(2):38. doi: 10.3390/biom8020038. Biomolecules. 2018. PMID: 29874862 Free PMC article. Review.
Cited by
-
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy.Biomedicines. 2024 Jan 11;12(1):155. doi: 10.3390/biomedicines12010155. Biomedicines. 2024. PMID: 38255260 Free PMC article. Review.
-
In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.PLoS Genet. 2015 Jun 9;11(6):e1005288. doi: 10.1371/journal.pgen.1005288. eCollection 2015 Jun. PLoS Genet. 2015. PMID: 26057580 Free PMC article.
-
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.Cell Stem Cell. 2012 Jul 6;11(1):36-49. doi: 10.1016/j.stem.2012.05.013. Epub 2012 Jun 7. Cell Stem Cell. 2012. PMID: 22683204 Free PMC article.
-
Hallmarks of ribosomopathies.Nucleic Acids Res. 2020 Feb 20;48(3):1013-1028. doi: 10.1093/nar/gkz637. Nucleic Acids Res. 2020. PMID: 31350888 Free PMC article. Review.
-
CryoEM structures of pseudouridine-free ribosome suggest impacts of chemical modifications on ribosome conformations.Structure. 2022 Jul 7;30(7):983-992.e5. doi: 10.1016/j.str.2022.04.002. Epub 2022 Apr 29. Structure. 2022. PMID: 35489333 Free PMC article.
References
-
- Artandi SE, Attardi LD (2005) Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 331: 881–890 - PubMed
-
- Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, Van Etten RA, Donato N, Hunter A, Dinsdale D, Tirro E, Vigneri P, Nicotera P, Dyer MJ, Holyoake T, Salomoni P et al. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119: 1109–1123 - PMC - PubMed
-
- Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660–665 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous